HomeDealsRhenopharma Group

Rhenopharma Group

Deal Type
Deal Type
Acquisition
Vital Sector
Sector
Healthcare
Completion Date
Completion Date
23rd June 2024
Deal Value
Deal Value
Not disclosed

Company Background

As a leading service provider in the pharmaceutical sector, Rhenopharma Group aims to provide comprehensive and customized solutions tailored to the specific needs of its customers. Headquartered in Basel and with locations worldwide, the Group generates annual sales of over 100 million Swiss francs and employs more than 300 people. Rhenopharma includes Rhenochem, Allpack and the recently acquired Konapharma.

Deal Summary

The acquired Konapharma AG, Allpack Group AG, and Rhenochem AG will form the Rhenopharma Group. As a contract manufacturer in the pharmaceutical industry, Konapharma complements the service offerings of pharmaceutical packaging company Allpack and Rhenochem, both family-owned companies with decades of extensive experience and expertise in the global pharmaceutical industry.

The Rhenopharma Group sets new standards in the pharmaceutical industry with its unique integrated end-to-end value chain (Supply Chain as a Service). This innovative concept enables the Group to offer pharmaceutical services to its customers worldwide, ranging from development, procurement, manufacturing and packaging to worldwide distribution. With the strategic expansion to include Konapharma, the Group offers its customers a comprehensive service that increases efficiency and opens up new opportunities in the pharmaceutical industry.

Proventis Partners acted as exclusive M&A and financing advisor to the buyer throughout the entire process. The Proventis Partners transaction team consisted of Jan Wetter (Partner), Dr. Christoph Studinka (Partner), Artur Maibach (Vice President) and Flavian Gmünder (Analyst).

Value Added

Proventis Partners acted as exclusive M&A and financing advisor to the buyer throughout the entire process. The Proventis Partners transaction team consisted of Jan Wetter (Partner), Dr. Christoph Studinka (Partner), Artur Maibach (Vice President) and Flavian Gmünder (Analyst).

Rhenopharma Group deal contacts

Key members of the Proventis Partners deal team crucial in the Rhenopharma Group transaction

Jan Wetter

Proventis Partners

Flavian Gmuender

Proventis Partners

Artur Maibach

Proventis Partners

Dr. Christoph Studinka

Proventis Partners